Mass spectrometric identification of human prostate cancer-derived proteins in serum of xenograft-bearing mice.
Lack of sensitivity and specificity of current tumor markers has intensified research efforts to find new biomarkers. The identification of potential tumor markers in human body fluids is hampered by large variability and complexity of both control and patient samples, laborious biochemical analyses, and the fact that the identified proteins are unlikely produced by the diseased cells but are due to secondary body defense mechanisms. In a new approach presented here, we eliminate these problems by performing proteomic analysis in a prostate cancer xenograft model in which human prostate cancer cells form a tumor in an immune-incompetent nude mouse. Using this concept, proteins present in mouse serum that can be identified as human will, by definition, originate from the human prostate cancer xenograft and might have potential diagnostic and prognostic value. Using one-dimensional gel electrophoresis, liquid chromatography, and mass spectrometry, we identified tumor-derived human nm23/nucleoside-diphosphate kinase (NME) in the serum of a nude mouse bearing the androgen-independent human prostate cancer xenograft PC339. NME is known to be involved in the metastatic potential of several tumor cells, including prostate cancer cells. Furthermore we identified six human enzymes involved in glycolysis (fructose-bisphosphate aldolase A, triose-phosphate isomerase, glyceraldehyde-3-phosphate dehydrogenase, alpha enolase, and lactate dehydrogenases A and B) in the serum of the tumor-bearing mice. The presence of human NME and glyceraldehyde-3-phosphate dehydrogenase in the serum of PC339-bearing mice was confirmed by Western blotting. Although the putative usefulness of these proteins in predicting prognosis of prostate cancer remains to be determined, the present data illustrate that our approach is a promising tool for the focused discovery of new prostate cancer biomarkers.
van den Bemd
Gert-Jan C M
GJ
Department of Urology, Josephine Nefkens Institute, Erasmus MC, 3000 DR, Rotterdam, The Netherlands.
Krijgsveld
Jeroen
J
Luider
Theo M
TM
van Rijswijk
Angelique L
AL
Demmers
Jeroen A A
JA
Jenster
Guido
G
D000595:Amino Acid Sequence; D000818:Animals; D015153:Blotting, Western; D006019:Glycolysis; D006801:Humans; D008297:Male; D013058:Mass Spectrometry; D051379:Mice; D008819:Mice, Nude; D008969:Molecular Sequence Data; D054778:NM23 Nucleoside Diphosphate Kinases; D009363:Neoplasm Proteins / Q000097:blood* / Q000737:chemistry*; D009368:Neoplasm Transplantation; D009701:Nucleoside-Diphosphate Kinase / Q000097:blood / Q000737:chemistry; D010455:Peptides / Q000737:chemistry; D011471:Prostatic Neoplasms / Q000097:blood / Q000737:chemistry*; D015203:Reproducibility of Results; D014183:Transplantation, Heterologous
D054778:NM23 Nucleoside Diphosphate Kinases; D009363:Neoplasm Proteins; D010455:Peptides; C517938:NME1 protein, human; C517939:Nme1 protein, mouse; D009701:Nucleoside-Diphosphate Kinase